A Study to Test How BI 1819479 is Taken up and Processed by the Body

NCT07065617 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped Company decision

Conditions

Healthy

Interventions

DRUG: [14C]BI 1819479
DRUG: BI 1819479
DRUG: BI 1819479 (C-14)

Sponsor

Boehringer Ingelheim